IRON DEFICIENCY ANEMIA TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global iron deficiency anemia treatment market is estimated to be valued at US$ 12.1 Bn in 2024 and is expected to exhibit a CAGR of 8.6% during the forecast period (2024-2031). Iron deficiency anemia is a very common nutritional deficiency that affects over a billion people worldwide, according to the World Health Organization. It occurs when the body does not have enough iron to produce hemoglobin, an essential protein in red blood cells that carries oxygen throughout the body. Symptoms can vary from fatigue and weakness to headaches, dizziness, and breathlessness. Left untreated, it can be a serious health condition and negatively impact physical and cognitive development especially in infants, young children and women. Global iron deficiency anemia treatment market is witnessing strong growth with emergence of new oral and injectable drugs having less side effects and higher efficacy.

Market Dynamics:

Global iron deficiency anemia treatment market growth is driven by growing prevalence of the condition globally especially among children and women. Key factors contributing to rising cases of iron deficiency anemia include poor dietary intake of iron-rich foods, blood loss during menstruation, and parasitic infections. According to WHO, approximately 40% of pregnant women worldwide suffer from anemia, which is expected to propel demand for effective therapeutic drugs. Development of novel drugs by leading players is a significant growth opportunity in this space. However, availability of alternative treatment options including supplements and plant-based remedies in developing economies can restrain commercial uptake of modern medications to some extent in the near future.

Key Features of the Study:

• This report provides in-depth analysis of the global iron deficiency anemia treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global iron deficiency anemia treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study includes AdvaCare Pharma, Otsuka Pharmaceutical Co., Ltd., Sanofi, Emcure Pharmaceuticals, Wellona Pharma, SiNi Pharma Pvt Ltd, Sun Pharmaceutical Industries Ltd., Zydus Group, Akebia Therapeutics., Rockwell Medical, Inc., AbbVie Inc., Pfizer, Inc., Velnex Medicare, PHAEDRUS LIFE SCIENCE PVT. LTD., Inopha International Co, Limited, PharmaNutra S.p.A., Pharmascience Inc., and American Regent, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global iron deficiency anemia treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global iron deficiency anemia treatment market

Detailed Segmentation-

• Drug Type:
• • Ferrous Sulfate
  • Ferrous Gluconate
  • Ferrous Fumerate
  • Ferric Hydroxide
  • Others
• Dosage Form:
• • Tablets
  • Capsules
  • Liquid
  • Others
• Distribution Channel:
• • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Region:
• • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AdvaCare Pharma
  • Otsuka Pharmaceutical Co., Ltd.
  • Sanofi
  • Emcure Pharmaceuticals
  • Wellona Pharma
  • SiNi Pharma Pvt Ltd
  • Sun Pharmaceutical Industries Ltd.
  • Zydus Group
  • Akebia Therapeutics.
  • Rockwell Medical, Inc.
  • AbbVie Inc.
  • Pfizer, Inc.
  • Velnex Medicare 
  • PHAEDRUS LIFE SCIENCE PVT. LTD. 
  • Inopha International Co, Limited
  • PharmaNutra S.p.A.
  • Pharmascience Inc.
  • American Regent, Inc.